Spyre Therapeutics
SYRE
#4131
Rank
NZ$4.65 B
Marketcap
NZ$60.00
Share price
3.53%
Change (1 day)
30.66%
Change (1 year)

Spyre Therapeutics (SYRE) Fails to deliver data

Key failure to deliver metrics for Spyre Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Spyre Therapeutics (SYRE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Spyre Therapeutics (SYRE) - since 2023

Volume in USD (price x number of shares), data since 2023

Spyre Therapeutics (SYRE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025NZ$22.2 M-52.63%
2024NZ$46.88 M446.09%
2023NZ$8.58 M